In the week of 14–20 July 2025, 49,598 samples were tested across 85 countries, with 1,829 positives (3.7%), indicating generally low but heterogeneous SARS‑CoV‑2 activity worldwide.
Over the 28 days from 23 June to 20 July 2025, 90 countries reported 90,333 new cases, a decrease from the prior 28-day period; 31 countries still showed >10% rises, underscoring localized upticks.
In the same 28-day window, 41 countries reported 858 deaths, down from 1,206 in the previous 28 days; 87% of deaths with age data in June 2025 occurred in people aged 65+.
WHO notes many countries have reduced or shifted to weekly reporting; figures reflect reported data and can change with retrospective updates.
Variants and virologic trendsWHO is tracking VOI JN.1 and multiple Variants Under Monitoring; as of week ending 20 July 2025, XFG accounted for 48% of sequences and NB.1.8.1 for 35% globally, with no evidence these pose added public health risk versus other circulating variants.
Hospitalizations and severityFrom 23 June to 20 July 2025, 5,516 hospitalizations and 176 ICU admissions were reported from subsets of countries, with some regions showing increasing trends, emphasizing ongoing monitoring needs especially for older populations.
How the data are compiled (WHO)
WHO statistics reflect reported, laboratory‑confirmed cases/deaths and are presented weekly to align with evolving national reporting practices; counts may be revised as countries correct or aggregate historical data.
Cumulative COVID-19 Impact: Top Countries (latest compiled figures)Note: Totals reflect publicly compiled dashboards frequently used by analysts and media; WHO emphasizes reporting variability and retrospective revisions.
test | test | test | test |
test | test | test | test |
test | test | test | test |
test | test | test | test |
test | test | test | test |
Figures above are drawn from global compilations of country reports commonly referenced for country-by-country comparisons.
WHO’s dashboard provides methodological context, definitions, and cautions regarding completeness and comparability across countries and over time.
Watch the interview of Prakash Diwan of prakashdiwan.in with Surabhi Upadhyay on CNBC-TV18, in which he shared his readings and outlook on specific stocks.
Indian exporters shipped goods worth USD 20.01 billion last month, lower than USD 21.35 billion provisionally reported in October.
There are thousands of SME‘s in India which are highly contributing to the manufacturing sector.
Watch the interview of SP Tulsian of sptulsian.com, Prakash Gaba of prakashgaba.com, Mithil Pradhan of Violet Arc Global, Parag Thakkar of HDFC Securities and Varun Goel of Motilal Oswal with Anuj Singhal and Sonia Shenoy on CNBC-TV18, in which they share their readings and outlook on specific stocks and sectors.
In CNBC-TV18's special series 'Hello GST', today's pick is textile industry, which has enjoyed tax-exemption for all these years.
To tackle the Delhi pollution menace, the Supreme Court (SC) is looking at a multipronged strategy.
Prakash Gaba of prakashgaba.com is of the view that Asian Paints may test Rs 890 and likes Godrej Consumer Products.
Varun Goel of Motilal Oswal has a positive view on oil & gas space.
SP Tulsian of sptulsian.com has a positive view on Dish TV with a view of six months.
Parag Thakkar of HDFC Securities recommends buying Pidilite Industries on dips and is bullish on Kotak Mahindra Bank.
Mithil Pradhan of Violet Arc Global recommends going long in Jet Airways.
Hemindra Hazari recommends avoiding the entire financial intermediary space because there is still lot of pain to come but if institutional investors have to be in the space then one should look at HDFC Bank and Kotak Mahindra Bank.
Chandan Taparia, Derivative & Technical Analyst at Anand Rathi Securities recommends buying Dabur India with a target of Rs 288.
Nooresh Merani Of Asian Market Securities is of the view that one can hold Hindustan Petroleum Corporation and State Bank of India.
The company has initiated the expansion of its Chopanki plant and targets Rs 6500 crore topline by 2020.
JC Sharma, VC and MD, Sobha Developers says the company may not meet its sales value target due to slowdown in Chennai and Bangalore markets.
Amit Harchekar, Chief Technical Strategist at A PLUS Analytics recommends shorting SBI as the stock should slide below Rs 200.
Chandan Taparia, Derivative & Technical Analyst at Anand Rathi Securities recommends buying Sun Pharmaceutical Industries with a target of Rs 800.
CNBC-TV18's Ekta Batra lists six stocks that you should focus on.
Prakash Gaba of prakashgaba.com recommends buying Colgate Palmolive, Exide Industries, HDFC, Hindustan Unilever and UPL.
Indian international cricketer
Prime Minister
Businessman
Indian Javelin Thrower
Indian Spiritual Guru